~~<i id='A429088155'><strike id='A429088155'><tt id='A429088155'><pre id='A429088155'></pre></tt></strike></i>~~

Home» explore» comprehensive

comprehensive

author：hotspot 2025-08-21 16:37:23 Page View：76

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dairy farmers resist CDC push for PPE against bird flu virus
Next article： Novavax promises a turnaround & Lilly roils the obesity market

explore

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

Sepsis can kill a child within hours. Here's how hospitals are fighting back

ErosDervishiforSTATFORTWORTH,Texas—Itmightstartoutlookinglikenotmuchmorethananordinarychildhoodfever

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Black vets could get higher VA benefits if race not used in lung test

AdobeRemovingapatient’sracefromanequationusedtoassesslungfunction—achangecalledforbyhealthequityadvo

WSS

comprehensive

comprehensive

leisure time

explore

Black vets could get higher VA benefits if race not used in lung test